Published in Can J Cardiol on March 01, 2009
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol (1992) 12.18
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 8.76
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
Natural history of Brugada syndrome: insights for risk stratification and management. Circulation (2002) 3.10
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation (2000) 2.81
Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation (2001) 2.65
Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat (2003) 2.24
Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning. N Engl J Med (1999) 2.10
Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol (2000) 2.08
Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation (2005) 1.94
Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol (2004) 1.81
Enhanced Na(+) channel intermediate inactivation in Brugada syndrome. Circ Res (2000) 1.74
Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:. J Cardiovasc Electrophysiol (2004) 1.69
Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circ Res (2001) 1.44
Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. Circ Res (2004) 1.43
Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation (2002) 1.43
Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome. Circ Res (2002) 1.11
Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol (2004) 1.01
Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation (2005) 0.91
High-efficiency multiplex capillary electrophoresis single strand conformation polymorphism (multi-CE-SSCP) mutation screening of SCN5A: a rapid genetic approach to cardiac arrhythmia. Clin Genet (2006) 0.91
Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A. J Cardiovasc Electrophysiol (2005) 0.84
The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet (1985) 4.60
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA (1999) 2.56
Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med (2001) 2.52
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46
Evidence for distinct substrate specificities of importin alpha family members in nuclear protein import. Mol Cell Biol (1999) 2.27
Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest (1991) 2.11
Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther (2007) 2.06
Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome. Nat Genet (2000) 2.03
Adipose tissue triglyceride turnover, de novo lipogenesis, and cell proliferation in humans measured with 2H2O. Am J Physiol Endocrinol Metab (2003) 2.00
Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem (2001) 1.78
Characterization of sodium channel alpha- and beta-subunits in rat and mouse cardiac myocytes. Circulation (2001) 1.73
Regulation of the epithelial Na+ channel by Nedd4 and ubiquitination. Kidney Int (2000) 1.67
Do blood levels of neuron-specific enolase and S-100 protein reflect cognitive dysfunction after coronary artery bypass? Acta Anaesthesiol Scand (1999) 1.57
[Recommendations for clinical-chemical departments: lipid-lipoprotein analysis]. Ugeskr Laeger (1990) 1.47
S-100b and neuron-specific enolase in patients with fulminant hepatic failure. Liver Transpl (2001) 1.43
Pharmacological modulation of SK3 channels. Neuropharmacology (2001) 1.42
Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: A computational analysis. Circulation (2000) 1.41
A novel missense mutation, Leu390Val, in the cardiac beta-myosin heavy chain associated with pronounced septal hypertrophy in two families with hypertrophic cardiomyopathy. Scand Cardiovasc J (2000) 1.41
Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations. J Med Genet (2001) 1.33
Mutational spectrum in the cardioauditory syndrome of Jervell and Lange-Nielsen. Hum Genet (2000) 1.29
The early IL-6 and IL-10 response in trauma is correlated with injury severity and mortality. Acta Anaesthesiol Scand (2009) 1.28
Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J Clin Invest (1997) 1.27
Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J Clin Microbiol (1998) 1.25
Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab (1993) 1.24
Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1. Eur J Hum Genet (1998) 1.22
Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol (2001) 1.18
Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40. Eur J Hum Genet (2001) 1.17
Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart (2008) 1.17
Screening for mutations and polymorphisms in the genes KCNH2 and KCNE2 encoding the cardiac HERG/MiRP1 ion channel: implications for acquired and congenital long Q-T syndrome. Clin Chem (2001) 1.17
Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype. Arch Dis Child (2001) 1.16
Disruption of the vasopressin 1b receptor gene impairs the attack component of aggressive behavior in mice. Genes Brain Behav (2006) 1.16
KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology (2001) 1.15
The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif. Infect Immun (1998) 1.14
Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med (1990) 1.13
Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol (2004) 1.13
Early manifestations of the carbohydrate-deficient glycoprotein syndrome. J Pediatr (1993) 1.09
Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406. Hum Mol Genet (1994) 1.09
An outbreak of congenital rubella in Chicago. JAMA (1982) 1.08
Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem (2000) 1.08
Assignment of the gene for cystathionine beta-synthase to human chromosome 21 in somatic cell hybrids. Hum Genet (1984) 1.08
Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Mol Genet Metab (2001) 1.07
Comparative three-dimensional analysis of CT-scans of the calvaria and cranial base in Apert and Crouzon syndromes. J Craniomaxillofac Surg (1993) 1.06
Clustering of mutations associated with mild Marfan-like phenotypes in the 3' region of FBN1 suggests a potential genotype-phenotype correlation. Am J Med Genet (2000) 1.05
Dental manifestations of osteogenesis imperfecta and abnormalities of collagen I metabolism. J Craniofac Genet Dev Biol (1998) 1.05
Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology (1995) 1.03
Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. J Clin Endocrinol Metab (1999) 1.02
Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathy. J Med Genet (2010) 1.02
High incidence of propionic acidemia in greenland is due to a prevalent mutation, 1540insCCC, in the gene for the beta-subunit of propionyl CoA carboxylase. Am J Hum Genet (2000) 1.02
Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli. Eur J Hum Genet (1999) 1.02
Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med (1997) 1.01
Failure of short-term mannose therapy of patients with carbohydrate-deficient glycoprotein syndrome type 1A. Acta Paediatr (1998) 1.01
Intrathecal activation of the complement system and disability in multiple sclerosis. J Neurol Sci (1998) 0.99
The phenotypic variability of diastrophic dysplasia. J Pediatr (1978) 0.99
Homocystinuria: biogenesis of cystathionine beta-synthase subunits in cultured fibroblasts and in an in vitro translation system programmed with fibroblast messenger RNA. Am J Hum Genet (1984) 0.99
Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands. Eur J Hum Genet (2001) 0.98
An ERG channel inhibitor from the scorpion Buthus eupeus. J Biol Chem (2001) 0.98
Messenger ribonucleic acid levels of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein: expression in human reproductive and nonreproductive tissues. Biol Reprod (1999) 0.98
Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care (2000) 0.97
Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy. Clin Genet (2011) 0.97
Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab (2002) 0.97
Characterizations of a loss-of-function mutation in the Kir3.4 channel subunit. Biochem Biophys Res Commun (2007) 0.96
Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women. Am J Physiol Endocrinol Metab (2000) 0.95
Temperature-controlled radiofrequency ablation of cardiac tissue: an in vitro study of the impact of electrode orientation, electrode tissue contact pressure and external convective cooling. J Interv Card Electrophysiol (1999) 0.95
Effect of the I(to) activator NS5806 on cloned K(V)4 channels depends on the accessory protein KChIP2. Br J Pharmacol (2010) 0.94
Immunochemical studies on cultured fibroblasts from patients with homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet (1982) 0.94
A novel dominant mutation of the Nav1.4 alpha-subunit domain I leading to sodium channel myotonia. Neurology (2008) 0.94
Pregnancy-associated plasma protein-a is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endocrinology (2001) 0.94
Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. J Inherit Metab Dis (2007) 0.93
Biosynthesis of human cystathionine beta-synthase in cultured fibroblasts. J Biol Chem (1984) 0.93
Molecular basis of the delayed rectifier current I(ks)in heart. J Mol Cell Cardiol (2001) 0.92
Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production. Am J Physiol Endocrinol Metab (2001) 0.92
Clinical and genetic characteristics of alpha cardiac actin gene mutations in hypertrophic cardiomyopathy. J Med Genet (2004) 0.92
Variable clinical expression in a family with OI type IV due to deletion of three base pairs in COL1A1. Clin Genet (1996) 0.91
Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995-2000: a national cohort study. Hum Reprod (2008) 0.91
High-efficiency multiplex capillary electrophoresis single strand conformation polymorphism (multi-CE-SSCP) mutation screening of SCN5A: a rapid genetic approach to cardiac arrhythmia. Clin Genet (2006) 0.91
Subtle brain damage cannot be detected by measuring neuron-specific enolase and S-100beta protein after carotid endarterectomy. J Cardiothorac Vasc Anesth (2000) 0.90
Do blood concentrations of neurone specific enolase and S-100 beta protein reflect cognitive dysfunction after abdominal surgery?ISPOCD Group. Br J Anaesth (2000) 0.90
Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. Cardiovasc Res (2008) 0.90
Ultrastructure of methanotrophic yeasts. J Bacteriol (1980) 0.90
Quantification, by solid-phase minisequencing, of the telomeric and centromeric copies of the survival motor neuron gene in families with spinal muscular atrophy. Hum Mol Genet (1997) 0.89
Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89
Collagen-derived markers of bone metabolism in osteogenesis imperfecta. Acta Paediatr (1998) 0.89
Biosynthesis and proteolytic activation of cystathionine beta-synthase in rat liver. J Biol Chem (1984) 0.89
Recent developments in high-throughput mutation screening. Pharmacogenomics (2001) 0.89
Folate and neural tube defects. Recommendations from a Danish working group. Dan Med Bull (1998) 0.89
Osteogenesis imperfecta: mosaicism and refinement of the genotype-phenotype map in OI type III. Mutations in brief no. 242. Online. Hum Mutat (1999) 0.88
Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV. Acta Paediatr (1997) 0.88
Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis. Hepatology (1995) 0.88
Fine mapping of the gene for carbohydrate-deficient glycoprotein syndrome, type I (CDG1): linkage disequilibrium and founder effect in Scandinavian families. Genomics (1997) 0.88
Neonatal screening for galactosemia by quantitative analysis of hexose monophosphates using tandem mass spectrometry: a retrospective study. Clin Chem (2001) 0.87
A single strand conformation polymorphism/heteroduplex (SSCP/HD) method for detection of mutations in 15 exons of the KVLQT1 gene, associated with long QT syndrome. Clin Chim Acta (1999) 0.87
Cholesterol-lowering diets may increase the food costs for Danish children. A cross-sectional study of food costs for Danish children with and without familial hypercholesterolaemia. Eur J Clin Nutr (1993) 0.87
The Val606Met mutation in the cardiac beta-myosin heavy chain gene in patients with familial hypertrophic cardiomyopathy is associated with a high risk of sudden death at young age. Am J Cardiol (2001) 0.87
Prepubertal growth in congenital disorder of glycosylation type Ia (CDG-Ia). Arch Dis Child (2002) 0.87
FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. Dermatology (2010) 0.86
Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities. Leukemia (2002) 0.86
Screening for carriers of cystic fibrosis among pregnant women: a pilot study. Eur J Hum Genet (1993) 0.86